14.29
price up icon2.95%   0.41
pre-market  プレマーケット:  14.50   0.21   +1.47%
loading
前日終値:
$13.88
開ける:
$14.09
24時間の取引高:
274.61K
Relative Volume:
0.56
時価総額:
$984.26M
収益:
$62.71M
当期純損益:
$-112.51M
株価収益率:
-9.4636
EPS:
-1.51
ネットキャッシュフロー:
$-96.01M
1週間 パフォーマンス:
+4.92%
1か月 パフォーマンス:
+1.06%
6か月 パフォーマンス:
+46.11%
1年 パフォーマンス:
+44.64%
1日の値動き範囲:
Value
$13.88
$14.38
1週間の範囲:
Value
$13.58
$14.63
52週間の値動き範囲:
Value
$7.97
$17.70

Zymeworks Inc. Stock (ZYME) Company Profile

Name
名前
Zymeworks Inc.
Name
セクター
Healthcare (1176)
Name
電話
604-678-1388
Name
住所
1385 West 8th Avenue, Suite 540, Vancouver, BC
Name
職員
170
Name
Twitter
@ZymeworksInc
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
ZYME's Discussions on Twitter

ZYME を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ZYME
Zymeworks Inc.
14.29 984.26M 62.71M -112.51M -96.01M -1.51
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
427.89 110.19B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
687.80 75.58B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
647.39 38.71B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
264.99 34.18B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
117.25 28.11B 3.30B -501.07M 1.03B -2.1146

Zymeworks Inc. Stock (ZYME) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-16 アップグレード JP Morgan Neutral → Overweight
2024-11-07 アップグレード Leerink Partners Market Perform → Outperform
2024-11-01 ダウングレード Wells Fargo Overweight → Equal Weight
2023-03-21 再開されました Wells Fargo Overweight
2023-01-04 繰り返されました H.C. Wainwright Neutral
2022-12-20 アップグレード Jefferies Hold → Buy
2022-11-01 ダウングレード H.C. Wainwright Buy → Neutral
2022-10-21 ダウングレード SVB Leerink Outperform → Mkt Perform
2022-10-04 再開されました Wells Fargo Overweight
2022-05-05 アップグレード Guggenheim Neutral → Buy
2022-03-15 開始されました Evercore ISI Outperform
2021-12-10 アップグレード SVB Leerink Mkt Perform → Outperform
2021-11-17 再開されました Guggenheim Neutral
2021-10-07 開始されました Jefferies Hold
2021-03-31 開始されました Credit Suisse Outperform
2021-02-25 ダウングレード SVB Leerink Outperform → Mkt Perform
2021-02-08 再開されました H.C. Wainwright Buy
2021-01-25 ダウングレード Citigroup Buy → Neutral
2020-09-29 再開されました JP Morgan Neutral
2020-08-06 開始されました SVB Leerink Outperform
2020-01-10 開始されました Wolfe Research Outperform
2019-12-09 開始されました JP Morgan Neutral
2019-11-25 開始されました H.C. Wainwright Buy
2019-11-20 開始されました Guggenheim Buy
2019-09-30 アップグレード Raymond James Outperform → Strong Buy
2019-08-30 開始されました Stifel Buy
2019-07-18 開始されました Deutsche Bank Buy
2018-05-11 アップグレード Barclays Underweight → Equal Weight
2018-03-19 開始されました Raymond James Outperform
すべてを表示

Zymeworks Inc. (ZYME) 最新ニュース

pulisher
Jan 21, 2025

EcoR1 Capital, LLC Expands Stake in Zymeworks Inc with Strategic Acquisition - GuruFocus.com

Jan 21, 2025
pulisher
Jan 19, 2025

Assenagon Asset Management S.A. Boosts Stake in Zymeworks Inc. (NYSE:ZYME) - MarketBeat

Jan 19, 2025
pulisher
Jan 17, 2025

Engineered Multispecific Antibodies Innovation Research Report 2024: Patent Trends Show a Noticeable Surge in 2023 with Regeneron, Roche, and Amgen Emerging as the Top Patent Filers - GlobeNewswire Inc.

Jan 17, 2025
pulisher
Jan 16, 2025

Opinion: Four trends to watch in B.C.'s tech sector - Business in Vancouver

Jan 16, 2025
pulisher
Jan 16, 2025

Zymeworks (NYSE:ZYME) Shares Gap Up on Insider Buying Activity - MarketBeat

Jan 16, 2025
pulisher
Jan 15, 2025

EcoR1 Capital, LLC Increases Stake in Zymeworks Inc - GuruFocus.com

Jan 15, 2025
pulisher
Jan 15, 2025

ZYME (Zymeworks) Total Stockholders Equity : $366.98 Mil (As of Sep. 2024) - GuruFocus.com

Jan 15, 2025
pulisher
Jan 15, 2025

Insider Buying: Zymeworks Inc. (NYSE:ZYME) Director Acquires 74,125 Shares of Stock - MarketBeat

Jan 15, 2025
pulisher
Jan 15, 2025

Ecor1 capital acquires $2.28 million in Zymeworks stock By Investing.com - Investing.com Nigeria

Jan 15, 2025
pulisher
Jan 15, 2025

Ecor1 Capital, Llc Buys 39,029 Shares of Zymeworks Inc. (NYSE:ZYME) Stock - MarketBeat

Jan 15, 2025
pulisher
Jan 15, 2025

Ecor1 capital acquires $2.28 million in Zymeworks stock - Investing.com

Jan 15, 2025
pulisher
Jan 10, 2025

Zymeworks Inc. (NYSE:ZYME) Director Ecor1 Capital, Llc Acquires 204,098 Shares of Stock - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Ecor1 Capital, Llc Purchases 21,021 Shares of Zymeworks Inc. (NYSE:ZYME) Stock - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Ecor1 capital increases stake in Zymeworks with $2.97 million purchase By Investing.com - Investing.com South Africa

Jan 10, 2025
pulisher
Jan 10, 2025

Ecor1 capital increases stake in Zymeworks with $2.97 million purchase - Investing.com

Jan 10, 2025
pulisher
Jan 10, 2025

Zymeworks in Focus for Insider Activity: Catalysts Ahead - Benzinga

Jan 10, 2025
pulisher
Jan 08, 2025

Zymeworks Outlines Strategic Priorities and Outlook for 2025 and 2026 - The Korea Bizwire

Jan 08, 2025
pulisher
Jan 08, 2025

Zymeworks Sets Strategic Milestones for 2025-2026 with Focus on Novel Therapeutics - TipRanks

Jan 08, 2025
pulisher
Jan 08, 2025

Zymeworks says it has enough cash to operate through H2 2027 - Seeking Alpha

Jan 08, 2025
pulisher
Jan 08, 2025

Zymeworks Unveils 2025 Pipeline Strategy: Multiple INDs Planned, $324M Cash Position Supports Growth - StockTitan

Jan 08, 2025
pulisher
Jan 07, 2025

Wall Street Analysts Believe Zymeworks (ZYME) Could Rally 41.36%: Here's is How to Trade - Yahoo Finance

Jan 07, 2025
pulisher
Jan 07, 2025

Zymeworks CEO Kenneth Galbraith sells $855,016 in stock By Investing.com - Investing.com Australia

Jan 07, 2025
pulisher
Jan 07, 2025

Zymeworks chief scientific officer sells shares worth $316,390 By Investing.com - Investing.com Australia

Jan 07, 2025
pulisher
Jan 06, 2025

Zymeworks Inc. (NYSE:ZYME) CEO Sells $854,781.72 in Stock - MarketBeat

Jan 06, 2025
pulisher
Jan 06, 2025

Insider Selling: Zymeworks Inc. (NYSE:ZYME) EVP Sells 11,110 Shares of Stock - MarketBeat

Jan 06, 2025
pulisher
Jan 06, 2025

Paul Andrew Moore Sells 21,200 Shares of Zymeworks Inc. (NYSE:ZYME) Stock - MarketBeat

Jan 06, 2025
pulisher
Jan 06, 2025

Zymeworks chief scientific officer sells shares worth $316,390 - Investing.com

Jan 06, 2025
pulisher
Jan 06, 2025

Zymeworks CEO Kenneth Galbraith sells $855,016 in stock - Investing.com

Jan 06, 2025
pulisher
Jan 04, 2025

Zymeworks (NYSE:ZYME) Shares Gap Up After Insider Buying Activity - Defense World

Jan 04, 2025
pulisher
Jan 03, 2025

Zymeworks (NYSE:ZYME) Shares Gap Up Following Insider Buying Activity - MarketBeat

Jan 03, 2025
pulisher
Jan 02, 2025

Ecor1 Capital, Llc Buys 157,880 Shares of Zymeworks Inc. (NYSE:ZYME) Stock - MarketBeat

Jan 02, 2025
pulisher
Jan 02, 2025

Zymeworks Inc. (NYSE:ZYME) Director Ecor1 Capital, Llc Buys 58,988 Shares - MarketBeat

Jan 02, 2025
pulisher
Jan 02, 2025

Geode Capital Management LLC Grows Stock Position in Zymeworks Inc. (NYSE:ZYME) - Defense World

Jan 02, 2025
pulisher
Dec 28, 2024

Zymeworks Inc. (NYSE:ZYME) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Dec 28, 2024
pulisher
Dec 27, 2024

Insider Buying: Zymeworks Inc. (NYSE:ZYME) Director Purchases 11,958 Shares of Stock - MarketBeat

Dec 27, 2024
pulisher
Dec 27, 2024

Zymeworks Inc. (NYSE:ZYME) Director Ecor1 Capital, Llc Purchases 16,692 Shares - MarketBeat

Dec 27, 2024
pulisher
Dec 27, 2024

Ecor1 capital increases stake in Zymeworks with $1.88 million purchase By Investing.com - Investing.com Canada

Dec 27, 2024
pulisher
Dec 27, 2024

Ecor1 capital increases stake in Zymeworks with $1.88 million purchase - Investing.com India

Dec 27, 2024
pulisher
Dec 27, 2024

Zymeworks Inc. (NYSE:ZYME) Shares Acquired by Barclays PLC - MarketBeat

Dec 27, 2024
pulisher
Dec 25, 2024

Zymeworks Inc. (NYSE:ZYME) Shares Bought by State Street Corp - MarketBeat

Dec 25, 2024
pulisher
Dec 20, 2024

Zymeworks (NYSE:ZYME) Shares Down 2.4%Here's Why - MarketBeat

Dec 20, 2024
pulisher
Dec 20, 2024

Y Intercept Hong Kong Ltd Has $147,000 Stock Holdings in Zymeworks Inc. (NYSE:ZYME) - MarketBeat

Dec 20, 2024

Zymeworks Inc. (ZYME) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
大文字化:     |  ボリューム (24 時間):